• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Sainsbury’s stock higher on hopes of interest from Morrisons loser

October 4, 2021 by David Barret Leave a Comment

October 4, 2021

LONDON (Reuters) -Shares in British supermarket group Sainsbury’s rose as much as 3.7% on Monday on hopes SoftBank’s Fortress Investment, which lost out in the auction for Morrisons, may turn its attention to an even bigger player in UK grocery.

Sainsbury’s stock was up 4.2 pence at 288.9 pence at 0858 GMT, valuing the business at 6.7 billion pounds ($9.1 billion).

Fortress was defeated in Saturday’s shootout for Morrisons, Britain’s No. 4 supermarket group, bidding 286 pence a share – a penny less than rival Clayton, Dubilier & Rice.

However, managing partner Joshua A Pack signalled Fortress remained interested in UK assets.

“The UK remains a very attractive investment environment from many perspectives, and we will continue to explore opportunities to help strong management teams grow their businesses and create long-term value,” he said in a statement.

A spokesperson for Fortress declined to comment on Sainsbury’s, which trails only market leader Tesco in UK grocery sales.

A Sainsbury’s spokesperson also declined to comment.

Shares in Sainsbury’s are up 28% this year, buoyed by bid speculation.

That started in April when Czech billionaire Daniel Kretinsky raised his stake in Sainsbury’s to just under 10% and has been fuelled by the bid battle for Morrisons and signs CEO Simon Roberts’s “food first” strategy is starting to work.

($1 = 0.7381 pounds)

(Reporting by James Davey, editing by Ed Osmond)

Source Link Sainsbury’s stock higher on hopes of interest from Morrisons loser

David Barret
David Barret

Related posts:

  1. HPE signs multi-billion dollar NSA computing deal
  2. EU’s chief executive warns against ‘pandemic of the unvaccinated’
  3. Ghana’s economy grew by 8.9% in second quarter, president says
  4. U.S. chipmaker Micron forecasts first-quarter revenue below estimates

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • What Are Lagrange Points, And Why Are They Important?
  • Fish Left The Ocean 10 Million Years Earlier Than Thought, JWST Spots Tiny New Moon Just Outside Uranus’s Rings, And Much More This Week
  • IFLScience We Have Questions: Do Humans Have Pheromones?
  • The Least Visited Place On Earth Is Disappearing Quickly – And May Be Reborn Online
  • Climate Models Have Predicted Sea Level Rise Almost Perfectly For 30 Years
  • Atlantic Great White Sharks Are Creeping Up The East Coast Of The US And Canada
  • New World Screwworm: What Is It, And Why Is It Hitting The Headlines?
  • Australia Has Its Very Own “Area 51”
  • Think You Know What A Bald Eagle Sounds Like? Think Again
  • GLP-1s: Your No-Nonsense Guide To The Latest Science Behind The “Skinny Jabs”
  • Deep In Virginia, When The Light Hits Just Right, A “Rainbow Swamp” Appears
  • New Approach To Einstein’s Equations Might Tell Us What Happened Before The Big Bang
  • Air Pollution From Oil And Gas Causes 91,000 Premature Deaths In The US Every Year
  • The Secret To Saving Bees Might Be… Yeast?
  • Miles Below Earth’s Surface, Scientists Found A Giant Ecosystem Teeming With Life
  • Asteroids Bennu And Ryugu Could Be Siblings – And We Might Have Found Their Parent
  • Meet The Spectral Bat, The Largest Carnivorous Bat Species In The World
  • Have You Seen This Snake? Florida Wants Your Help Finding Rare Species Seen Once In 50 Years
  • Plague Confirmed In Lake Tahoe Area For First Time In 5 Years, California Officials Say
  • Supergiant Star Spotted Blowing Milky Way’s Largest Bubble Of Its Kind, Surprising Astronomers
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version